Dosing: Adult Antimicrobial Dosing, Non-dialysis
| Indication | CrCl > 60 mL/min | 30-60 mL/min | 15-30 mL/min | < 15 mL/min |
|---|---|---|---|---|
| Gram-negative or Nocardia infections* | 500 mg IV q6h | 250 mg IV q6h | 250 mg IV q8h | Use alternative of consult ID pharmacy |
| Nontuberculous Mycobacteria** | 1000 mg IV q12h | 500 mg IV q12h | 250 mg IV q12h | Use alternative or consult ID pharmacy |
| Carbapenem-resistant Acinetobacter baumannii infections, with sulbactam-durlobactam | 1000 mg IV q6h | 500 mg IV q6h | 250 mg IV q6h | Use alternative or consult ID pharmacy |
*If using imipenem-cilastatin for the treatment of confirmed Pseudomonas infection, higher doses and/or extended infusion may be needed. Contact Antimicrobial Stewardship or Infectious Diseases for assistance.
**Higher doses may be required for elevated imipenem MICs (8-16)
Dosing: Antimicrobial Dosing in Intermittent & Continuous Hemodialysis
| Indication | Intermittent Hemodialysis | Continuous Hemodialysis |
|---|---|---|
| Gram-negative or Nocardia infections* | 500 mg IV q12h | 1000 mg IV x1 dose, then 250 mg IV q6h |
| Nontuberculous mycobacterial infections** | 500 mg IV q12h | 1000 mg IV x 1, then 250 mg IV q12h |
| Carbapenem-resistant Acinetobacter baumannii infections, with sulbactam-durlobactam | 500 mg IV q12h | 1000 mg IV x 1, then 500 mg IV q6h |
*If using imipenem-cilastatin for the treatment of confirmed Pseudomonas infection, higher doses and/or extended infusion may be needed. Contact Antimicrobial Stewardship or Infectious Diseases for assistance.
**Higher doses may be required for elevated imipenem MICs (8-16)
Dialysis Notes
Restricted to ID or Antimicrobial Stewardship